XML 65 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions
3 Months Ended
Mar. 31, 2012
Acquisitions  
Acquisitions

(10) Acquisitions

        The following table summarizes the purchase prices and opening balance sheets for the acquisition of 90.023% controlling interest in Molycorp Silmet on April 1, 2011 and of MMA on April 15, 2011 (in thousands):

Effective acquisition date for financial reporting purposes:
  Molycorp Silmet
April 1, 2011
  MMA
April 15, 2011
 

Purchase consideration:

             

Cash consideration

  $ 9,021   $ 17,500  

Fair value of common stock

    72,653      
           

Total purchase consideration

  $ 81,674   $ 17,500  
           

The fair values of the assets and liabilities acquired:

             

Cash

  $ 105   $ 6,395  

Accounts receivable and other current assets

    8,626     5,474  

Inventory

    37,404     11,327  

Property and equipment, net

    63,393     4,512  

Intangible assets subject to amortization

    2,669      

Goodwill

    1,455     1,977  

Liabilities

    (19,974 )   (8,989 )

Deferred tax liabilities

        (3,196 )

Long-term debt

    (3,184 )    

Noncontrolling interest

    (8,820 )    
           

Total purchase consideration

  $ 81,674   $ 17,500  
           

        The fair value of the accounts receivable acquired includes trade receivables of $5.0 million for Molycorp Silmet and $4.9 million for MMA. These trade receivables were collected by December 31, 2011. Molycorp Silmet's intangible assets subject to amortization relate primarily to customer relationships with a weighted average useful life of 15 years. Goodwill associated with the Molycorp Silmet acquisition arose primarily because of the acquired workforce. Goodwill associated with the MMA acquisition arose primarily because of the requirement to record a deferred tax liability for the difference between the assigned values and the tax basis of assets acquired and liabilities assumed at amounts that do not reflect fair value. The goodwill is not amortized and is not deductible for tax purposes. The fair value of the noncontrolling interest in Molycorp Silmet as of April 1, 2011 was valued using a combination of the market approach and income approach.

        The pro forma revenues, earnings and earnings per share of the Company for the first quarter of 2011 assuming the acquisition of Molycorp Silmet and MMA occurred on January 1, 2011, are as follows:

(In thousands, except per share amounts)
  Revenue   Net Income
(loss)
  Net Income (loss)
Attributable To
Molycorp
  EPS Basic  

Unaudited pro forma January 1, 2011 to March 31, 2011 (combined entity)

  $ 59,734   $ 4,916   $ 4,623   $ 0.04  

        The supplemental pro forma amounts are not necessarily indicative of the operating results that would have occurred if these acquisitions had taken place on January 1, 2011.

        The unaudited pro forma earnings of the combined entity were adjusted to exclude $1.1 million of purchase price variance MMA capitalized during the first quarter of 2011. This pro forma adjustment is based on currently available information and certain assumptions that management believes are reasonable.

Molycorp Silmet

        On April 1, 2011, Molycorp acquired 80% of the outstanding shares of Molycorp Silmet from AS Silmet Grupp in exchange for 1,593,419 shares of Molycorp common stock contractually valued at $80.0 million based on the average closing price of the Company's common stock as reported by The New York Stock Exchange for the 20 consecutive trading days immediately preceding April 1, 2011, the acquisition date.

        Generally, the acquisition-date fair value of shares of common stock transferred by the acquirer is the closing price of that stock on the same date adjusted by a discount that a market participant would require as a result of any restrictions on the sale or transferability of the stock. The fair value of common stock of $72.7 million disclosed in the table above is based on the closing price of the Company's common stock on the acquisition date, net of an estimated discount of 23% that a market participant would require given that issuance of the shares of common stock Molycorp transferred in consideration to AS Silmet Grupp was not registered under the Securities Act of 1933 and such shares were subject to certain lock-up provisions, which limited AS Silmet Grupp's ability to sell these shares. AS Silmet Grupp retained a 9.977% ownership interest in Molycorp Silmet on the acquisition date; Molycorp acquired the other 10.023% from Treibacher Industrie AG for $9.0 million in cash also on April 1, 2011.

        On October 24, 2011, the Company acquired the remaining 9.977% ownership interest in Molycorp Silmet for $10.0 million in cash, which resulted in an adjustment to Additional Paid-In Capital of $0.4 million for the difference between the consideration paid and the carrying value of the noncontrolling interest at October 24, 2011.

        The Molycorp Silmet acquisition provides Molycorp with a European base of operations and increases the Company's yearly REOs production capacity by approximately 3,000 mt. Molycorp Silmet sources a portion of rare earth feed stocks for production of its products primarily from the Molycorp Mountain Pass facility. The main focus of Molycorp Silmet is on the production of REOs and metals, including didymium metal, a critical component in the manufacture of NdFeB permanent rare earth magnets. Molycorp Silmet's manufacturing operation is located in Sillamäe, Estonia.

MMA

        On April 15, 2011, Molycorp completed the acquisition from Santoku Corporation ("Santoku") of all the issued and outstanding shares of capital stock of Santoku America, Inc., which is now known as MMA, an Arizona based corporation, in an all-cash transaction for $17.5 million. The acquisition provides Molycorp with access to certain intellectual properties relative to the development, processing and manufacturing of neodymium and samarium magnet alloy products. As part of the stock purchase agreement, Santoku will provide consulting services to Molycorp for the purpose of maintaining and enhancing the quality of MMA's products. Molycorp and Santoku also entered into five-year marketing and distribution agreements for the sale and distribution of neodymium and samarium magnet alloy products produced by each party. Additionally, the parties entered into a rare earth products purchase and supply agreement through which MMA will supply Santoku with certain rare earth alloys for a two-year period at prices equal to the feedstock cost plus the applicable product premium as such terms are defined in the agreement.